Quick Answer
ORTHOPEDIATRICS CORP reported Stockholders Equity of $346.60 million for the year ending 2025.
- ORTHOPEDIATRICS CORP showed a decrease of -2.2% in Stockholders Equity from 2024 to 2025.
- This data is from ORTHOPEDIATRICS CORP's annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: -$72.49 million | Q1 2018: $44.75 million | Q2 2018: $42.06 million | Q3 2018: $40.69 million | Q1 2019: $80.05 million | Q2 2019: $88.08 million | Q3 2019: $86.11 million | Q1 2020: $139.27 million | Q2 2020: $242.46 million | Q3 2020: $239.44 million | Q1 2021: $222.15 million | Q2 2021: $221.60 million | Q3 2021: $221.12 million | Q1 2022: $215.04 million | Q2 2022: $227.22 million | Q3 2022: $383.33 million | Q1 2023: $373.16 million | Q2 2023: $380.31 million | Q3 2023: $374.33 million | Q1 2024: $370.58 million | Q2 2024: $371.29 million | Q3 2024: $370.92 million | Q1 2025: $347.15 million | Q2 2025: $355.51 million | Q3 2025: $349.31 million.
- Over the full 12 years of available data (2014 to 2025), ORTHOPEDIATRICS CORP's Stockholders Equity has grown by 912.6%.
- Historical annual values: Fiscal year 2025: $346.60 million | Fiscal year 2024: $354.57 million | Fiscal year 2023: $377.03 million | Fiscal year 2022: $378.65 million | Fiscal year 2021: $225.37 million | Fiscal year 2020: $234.77 million | Fiscal year 2019: $142.36 million | Fiscal year 2018: $81.73 million | Fiscal year 2017: $47.50 million | Fiscal year 2016: -$65.31 million | Fiscal year 2015: -$54.11 million | Fiscal year 2014: -$42.65 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: